#evaxion risultati di ricerca
Evaxion presents new immune data from phase 2 trial with AI-designed personalized cancer vaccine EVX-01 $EVAX, #Evaxion crweworld.com/article/news-p…
Nasdaq Notifies Evaxion Biotech $EVAX, #EvaxionBiotech, #Evaxion crweworld.com/article/news-p…
The Real Numbers Behind Evaxion Biotech Revealed $EVAX, #EvaxionBiotech, #Evaxion crweworld.com/article/news-p…
LucidQuest Updates > Vaccines Weekly Update – October 3rd 2025 dlvr.it/TNRgbG #News #Evaxion #personalizedcancervaccine Comment below!
Evaxion to present new data at AACR Annual Meeting $EVAX, #Evaxion crweworld.com/article/news-p…
Evaxion A/S Licenses EVX-B3 Vaccine Candidate to MSD #evaxion #merck #evxb3 #evxb2 #gonorrhea #licensingagreement #pharma #preclinical pharmashots.com/28288/evaxion-…
pharmashots.com
Evaxion Licenses EVX-B3 Vaccine Candidate to Merck
Shots: Evaxion has granted Merck the rights to EVX-B3, a preclinical vaccine candidate under their Sep 2024 option & license agreement As per the deal, Merck will assume full responsibility & costs...
Recent clinical data confirms significantly improved predictive power of Evaxion 's AI-Immunology platform $EVAX, #Evaxion, #EvaxionBiotech crweworld.com/article/news-p…
Evaxion Biotech prices $10.8M public offering $EVAX, #Evaxion, #EvaxionBiotech crweworld.com/article/news-p…
Evaxion Biotech reveals new immune data from ongoing phase 2 trial: 80% of the EVX-01 vaccine targets trigger a tumor-reactive immune response $EVAX, #Evaxion, #EvaxionBiotech crweworld.com/article/news-p…
Evaxion Biotech: Phase 1 Dose Escalation Study Data Show 67% Objective Response Rate in Metastatic Melanoma for the AI-Designed Personalized Cancer Vaccine EVX-01 $EVAX, #EvaxionBiotech, #Evaxion crweworld.com/article/news-p…
Evaxion announces business update and third quarter 2025 financial results $EVAX, #Evaxion crweworld.com/article/news-p…
Evaxion expands AI-Immunology platform into autoimmune diseases $EVAX, #Evaxion crweworld.com/article/news-p…
Evaxion: Merck exercises its option on vaccine candidate EVX-B3 for a cash payment of $7.5M $EVAX, #Evaxion, #EvaxionBiotech, $MRK, #Merck, #MSD crweworld.com/article/news-p…
Key Date Approaching for Evaxion Shareholders $EVAX, #Evaxion, #EvaxionBiotech crweworld.com/article/news-p…
Evaxion announces business update and full year 2024 financial results $EVAX, #Evaxion, #EvaxionBiotech crweworld.com/article/news-p…
Evaxion significantly expands vaccine development collaboration with Merck $EVAX, #Evaxion, $MRK, #Merck, #MSD crweworld.com/article/news-p…
@EvaxionB rekryterar första patienten i fas IIb melanomstudie #BioStockSwe #lifescience #Evaxion biostock.se/2022/10/evaxio…
Firemný profil EVAXION SK, s.r.o. - firmynaslovensku.sk/evaxion-sk-s-r… #EVAXION #SK, #s.r.o.
Evaxion doses first patient in extension of phase 2 trial exploring the full potential of AI-designed personalized cancer vaccine EVX-01 $EVAX, #Evaxion, #EvaxionBiotech crweworld.com/article/news-p…
@EvaxionB säkrar kapital på upp till 40 miljoner USD #BioStockSwe #lifescience #Evaxion biostock.se/2022/06/evaxio…
Evaxion: AI-Immunology platform shows 86% vaccine target precision in phase 2 personalized cancer vaccine trial $EVAX, #Evaxion crweworld.com/article/news-p…
New data shows the unique scalability of Evaxion’s AI-Immunology platform in glioblastoma $EVAX, #Evaxion crweworld.com/article/news-p…
Evaxion announces last patient visit in one-year extension of phase 2 trial with personalized cancer vaccine EVX-01 $EVAX, #Evaxion crweworld.com/article/news-p…
Evaxion announces business update and second quarter 2025 financial results $EVAX, #Evaxion, #EvaxionBiotech crweworld.com/article/news-p…
Evaxion to present two-year clinical efficacy data from phase 2 trial with AI-designed personalized cancer vaccine EVX-01 at the ESMO Congress 2025 $EVAX, #Evaxion, #EvaxionBiotech crweworld.com/article/news-p…
Key Date Approaching for Evaxion Shareholders $EVAX, #Evaxion, #EvaxionBiotech crweworld.com/article/news-p…
Evaxion doses first patient in extension of phase 2 trial exploring the full potential of AI-designed personalized cancer vaccine EVX-01 $EVAX, #Evaxion, #EvaxionBiotech crweworld.com/article/news-p…
Evaxion Biotech reveals new immune data from ongoing phase 2 trial: 80% of the EVX-01 vaccine targets trigger a tumor-reactive immune response $EVAX, #Evaxion, #EvaxionBiotech crweworld.com/article/news-p…
Evaxion to announce business update and full year 2024 financial results $EVAX, #Evaxion, #EvaxionBiotech crweworld.com/article/news-p…
Evaxion Biotech to reveal new biomarker and immune data from the ongoing phase 2 trial for AI-designed personalized cancer vaccine EVX-01 $EVAX, #Evaxion, #EvaxionBiotech crweworld.com/article/news-p…
Nasdaq Notifies Evaxion Biotech $EVAX, #EvaxionBiotech, #Evaxion crweworld.com/article/news-p…
Evaxion announces closing of $10.8 million public offering $EVAX, #Evaxion, #EvaxionBiotech crweworld.com/article/news-p…
Evaxion Biotech prices $10.8M public offering $EVAX, #Evaxion, #EvaxionBiotech crweworld.com/article/news-p…
Evaxion to announce business update and third quarter 2024 financial results $EVAX, #Evaxion, #EvaxionBiotech crweworld.com/article/news-p…
Recent clinical data confirms significantly improved predictive power of Evaxion 's AI-Immunology platform $EVAX, #Evaxion, #EvaxionBiotech crweworld.com/article/news-p…
Evaxion significantly expands vaccine development collaboration with Merck $EVAX, #Evaxion, $MRK, #Merck, #MSD crweworld.com/article/news-p…
Evaxion Biotech: Phase 1 Dose Escalation Study Data Show 67% Objective Response Rate in Metastatic Melanoma for the AI-Designed Personalized Cancer Vaccine EVX-01 $EVAX, #EvaxionBiotech, #Evaxion crweworld.com/article/news-p…
Evaxion Hosts R&D Day and Unveils the Broad Potential of Its AI-Immunology Platform $EVAX, #Evaxion crweworld.com/article/news-p…
A partnership between #evaxion and @MSDintheUK @Merck is working on #artificialintelligence informed #vaccine discovery and design. #vaccinenation #vaccine #ai #technology #partnership vaccinenation.org/technology/eva…
vaccinenation.org
Evaxion and MSD complete initial phases of collaboration
In February 2024 Evaxion announced the “successful completion” of initial phases of a vaccine collaboration with MSD to combine “both organisations
The Real Numbers Behind Evaxion Biotech Revealed $EVAX, #EvaxionBiotech, #Evaxion crweworld.com/article/news-p…
Evaxion Announces Increased Focus and Fast-Tracking of its New AI Discovery to Patients zpr.io/NbePcQvT4HM4 #AIDiscovery #EVAXION #ArtificialIntelligence #DataAnalysis #DrugDiscovery
LucidQuest Updates > Vaccines Weekly Update – October 3rd 2025 dlvr.it/TNRgbG #News #Evaxion #personalizedcancervaccine Comment below!
@EIB agrees a EUR20 million loan with #Evaxion in Denmark. Together with @EUScienceInnov we support their development of vaccines and cures for infectious diseases based on #Artificialintelligence. Rapidly creating vaccines for new diseases is more important than ever. #IDFF
Biosynth are Proud to Supply Evaxion’s Phase IIb Trial for Personalized Neoantigen Peptide Cancer Vaccines "Proud to contribute to life-improving breakthroughs” Read full blog here...ow.ly/XyKL50LlrwP @Biosynth #Evaxion
#HealthTech wins ~#evaxion wins #FrostandSullivan2021 Enabling #Technology #Leadership Award ~@Implandata selected as a top 12 #HealthTechpreneur @IWCNavispace ~@CorWave receives 2021 #HealthTechAward in #MedTech through @FranceBiotech
Something went wrong.
Something went wrong.
United States Trends
- 1. JP Morgan N/A
- 2. Resident Evil N/A
- 3. Term N/A
- 4. Human Nature N/A
- 5. Toy Story N/A
- 6. Platner N/A
- 7. Man in the Mirror N/A
- 8. Bring Your Love N/A
- 9. FLY ME OUT N/A
- 10. Foss High School in Tacoma N/A
- 11. Rick Fox N/A
- 12. Maine N/A
- 13. Collins N/A
- 14. Cy Fair N/A
- 15. SNAP N/A
- 16. $AAPL N/A
- 17. Brian Harpole N/A
- 18. Cregger N/A
- 19. Foles N/A
- 20. Melendez N/A